Medtech companies Philips and Masimo are expanding their patient monitoring partnership to include the latter’s new W1 wearable.
The collaboration allows vital sign data from the W1 Watch to be sent to Philips’ patient monitoring ecosystem, so clinicians can monitor patients after they’ve been discharged from the hospital.
Fields Started W1. For consumer use in August. At the time, the company said the watch tracks oxygen saturation, pulse rate, respiration rate and, in a limited release, hydration levels. The device received the CE mark in Europe, but is still awaiting FDA approval.
“Extending our partnership with Philips in this way is a win-win for patients and physicians everywhere, and an important part of our multi-year plan to bring the best of hospital care to the home while improving access to quality hospital care.” Bilal Mohsin, Chief Operating Officer of Massimo Healthcare, said in a statement.
A big trend
Phillips and Fields First entered into a multi-year partnership In 2016 Before the deal was signed, the medtech companies were in the midst of patent and antitrust suits.
With the strategic partnership, they agreed to drop all pending lawsuits, and Phillips would not have to pay the $467 million it had been awarded. To Massimo in 2014. Instead, Philips agreed to provide a cash payment of $300 million and commit to marketing and product integration.
Use of remote patient monitoring Medicare beneficiaries increased. During the COVID-19 pandemic, according to the findings of a study published last year JAMA Internal Medicine. However, one Analysis in Health matters found that, although billing for RPM has increased, it is concentrated among a small number of primary care providers.
There are touting companies. Remote patient monitoring Technology, and consumers Wearable Increasingly adding health tracking features. Last year, Google revealed its smartwatch. That includes the health features of the tech giant’s Fitbit business.
Apple, whatever Add new versions Wearable has been used for its watch devices. research as well as. Over the summer, Northwestern University and Johns Hopkins University announced that they had Received a grant To study whether the Apple Watch could be used to help monitor and manage atrial fibrillation, an irregular heart rhythm.
#Phillips #Massimo #Expands #Remote #Patient #Monitoring #Partnership